Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection by E. N. Bessonova

Subjects: Get full text

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards? by D. T. Abdurakhmanov

Subjects: Get full text

Modern modes of chronic hepatitis B treatment in daily clinical practice by M. V. Mayevskaya, M. A. Morozova, S. A. Ondos, V. T. Ivashkin

Subjects: Get full text

Application of dicarbamin in treatment of patients by a chronic hepatitis C by D. Yu. Konstantinov, Ye. A. Konstantinova, L. L. Popova, E. A. Strebkova, A. A. Suzdaltsev

Subjects: Get full text

Chronic hepatitis C course at elderly and therapeutic approach by M. V. Mayevskaya, M. A. Morozova

Subjects: Get full text

Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort by Hye-Jin Yoo, Jae-Young Kim, Jeong-Ju Yoo, Hye Won Lee, Sang Gyune Kim, Young Seok Kim

Subjects: “…Antiviral therapy…”
Get full text

Modern modes of chronic hepatitis C treatment by V. T. Ivashkin, M. V. Mayevskaya, M. A. Morozova, Ye. O. Lyusina

Subjects: Get full text

Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C by S. N. Batskikh

Subjects: Get full text

Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study Protocol by Liu Wang, Xinyu Lei, Zhixuan Lan, Ruilin He, Zongbin Jiang

Subjects: Get full text

Telaprevir in treatment of chronic hepatitis C: safety issues by T. M. Ignatova

Subjects: Get full text

Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B by Qianqian Ma, Junzhao Ye, Ling Luo, Yanhong Sun, Wei Wang, Shiting Feng, Bing Liao, Bihui Zhong

Subjects: Get full text

Association of hepatitis B virus DNA levels with efficacy and safety and the impact of antiviral therapy on prognosis in liver cancer patients receiving immune checkpoint inhibitor... by Hongxia Cui, Su Li, Wu Lv, Jing Xiang

Subjects: Get full text

Chronic hepatitis B and risk of kidney involvement by M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin

Subjects: Get full text

Impact of Oseltamivir and Diabetes Development by Bor-Show Tzang, Chih-Chen Tzang, Pei-Hua Chuang, I-Ying Kuo, Yu-Chun Pan, Pei-Hsun Wu, Tsai-Ching Hsu

Subjects: “…antiviral therapy…”
Get full text

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm? by S. N. Batskikh

Subjects: Get full text

The CD4/CD8 ratio is associated with T lymphocyte functions in long-term virally suppressed patients with HIV by Qing Xiao, Fengting Yu, Liting Yan, Xiaojie Lao, Xuelei Liang, Hongxin Zhao, Liuyue Zhai, Zailin Yang, Xiaomei Zhang, Yao Liu, Fujie Zhang

Subjects: Get full text

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy by P. O. Bogomolov, N. A. Shub, N. A. Gasilova, A. A. Belyakova, T. G. Lidzhieva, E. A. Kondrasheva, N. A. Barsukova, M. V. Arapova, E. A. Isaeva, S. V. Koblov, M. V. Kalashnikov, O. S. Kuzymina, A. Yu. Demyanov, A. O. Bueverov, I. V. Maev

Subjects: Get full text

Virally-initiated pain states: phenotypes, mechanisms, and future directions by Sara A. Dochnal, Steven P. Cohen, Mark R. Hutchinson, Mark R. Hutchinson, Mark R. Hutchinson, Yury I. Miller, Tony L. Yaksh

Subjects: “…neurotropic infection and antiviral therapy…”
Get full text

Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches by Ayyaz Khan, Zakirullah, Shahid Wahab, Seong-Tshool Hong

Subjects: Get full text

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy by M. V. Mayevskaya, M. S. Zharkova, V. T. Ivashkin

Subjects: Get full text